Seeing Is Believing
RNA is currently covered by 10 analysts with an average price target of $92.93. This is a potential upside of $20.8 (28.84%) from yesterday's end of day stock price of $72.13.
Avidity Biosciences 's activity chart (see below) currently has 76 price targets and 82 ratings on display. The stock rating distribution of RNA is 96.15% BUY and 3.85% HOLD.
Analysts average stock forecasts to be materialized ratio is 67.52% with an average time for these price targets to be met of 374.77 days.
Highest price target for RNA is $96, Lowest price target is $59, average price target is $71.5.
Most recent stock forecast was given by KEAY NAKAE from CHARDAN CAPITAL on 11-Nov-2025. First documented stock forecast 07-Jul-2020.
Currently out of the existing stock ratings of RNA, 25 are a BUY (96.15%), 1 are a HOLD (3.85%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$72
$0.3 (0.42%)
$72
1 months 16 days ago
(11-Nov-2025)
12/16 (75%)
$1.3 (1.84%)
283
Buy
$74
$2.3 (3.21%)
$78
1 months 28 days ago
(29-Oct-2025)
0/2 (0%)
$4.35 (6.25%)
Buy
$72
$0.3 (0.42%)
$61
1 months 29 days ago
(28-Oct-2025)
3/4 (75%)
$2.07 (2.96%)
285
Buy
$72
$0.3 (0.42%)
$18
2 months ago
(27-Oct-2025)
3/4 (75%)
$2 (2.86%)
989
Buy
$65
$-6.7 (-9.34%)
$65
2 months ago
(27-Oct-2025)
17/18 (94.44%)
$-5 (-7.14%)
255
What is RNA (Avidity Biosciences ) average time for price targets to be met?
Which analyst has the current highest performing score on RNA (Avidity Biosciences ) with a proven track record?
Which analyst has the most public recommendations on RNA (Avidity Biosciences )?
Which analyst is the currently most bullish on RNA (Avidity Biosciences )?
Which analyst is the currently most reserved on RNA (Avidity Biosciences )?